Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer

European Journal of Cancer

Volumn 51, Issue 17, 2015, Pages 2553-2561

  Bos, A C R K ^a   Van Erning, F N ^a,b   Van Gestel, Y R B M ^a   Creemers, G J M ^c   Punt, C J A ^d   Van Oijen, M G H ^a,d   Lemmens, V E P P ^a,b  

^a Netherlands Comprehensive Cancer Organisation ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adjuvant chemotherapy; Colon cancer; Delays in chemotherapy; Survival; Timing

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; COLON CANCER; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PATIENT REFERRAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT DURATION; ADJUVANT CHEMOTHERAPY; CANCER STAGING; COLON; COLONIC NEOPLASMS; DRUG EFFECTS; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NETHERLANDS; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; CHEMOTHERAPY, ADJUVANT; COLON; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TIME FACTORS;

EID: 84948581450     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.08.016     Document Type: Article

References (32)

1. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, and et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 23 2004 2343 2351
2. I. Chau, and D. Cunningham Adjuvant therapy in colon cancer - what, when and how? Ann Oncol 17 9 2006 1347 1359
3. J.P. Kuebler, H.S. Wieand, M.J. O'Connell, R.E. Smith, L.H. Colangelo, G. Yothers, and et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 16 2007 2198 2204
4. S. Dube, F. Heyen, and M. Jenicek Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis Dis Colon Rectum 40 1 1997 35 41
5. G.S. Simpson, R. Smith, P. Sutton, A. Shekouh, C. McFaul, M. Johnson, and et al. The aetiology of delay to commencement of adjuvant chemotherapy following colorectal resection Int J Surg Oncol 2014 2014 670212
6. S. Yu, M. Shabihkhani, D. Yang, E. Thara, A. Senagore, H.J. Lenz, and et al. Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care Clin Colorectal Cancer 12 4 2013 275 279
7. T. Andre, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, and et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 19 2009 3109 3116
8. D.G. Haller, P.J. Catalano, J.S. Macdonald, M.A. O'Rourke, M.S. Frontiera, D.V. Jackson, and et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 J Clin Oncol 23 34 2005 8671 8678
9. C. Twelves, A. Wong, M.P. Nowacki, M. Abt, H. Burris 3rd, A. Carrato, and et al. Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 26 2005 2696 2704
10. H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, and et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Ann Oncol 23 10 2012 2479 2516
11. Netherlands Comprehensive Cancer Centre. National Evidence Based Guideline for Colon Cancer, 2014. Available from: < http://www.oncoline.nl/coloncarcinoom >.
12. U.D. Bayraktar, E. Chen, S. Bayraktar, L.R. Sands, F. Marchetti, A.J. Montero, and et al. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Cancer 117 11 2011 2364 2370
13. A. Chan, R. Woods, H. Kennecke, and S. Gill Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer Curr Oncol 21 4 2014 181 186
14. D. Hershman, M.J. Hall, X. Wang, J.S. Jacobson, R. McBride, V.R. Grann, and et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer Cancer 107 11 2006 2581 2588
15. I.S. Lima, Y. Yasui, A. Scarfe, and M. Winget Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada Cancer 117 16 2011 3833 3840
16. L.G. van der Geest, J.E. Portielje, M.W. Wouters, N.I. Weijl, B.C. Tanis, R.A. Tollenaar, and et al. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with stage III colon cancer Colorectal Dis 15 10 2013 e582 91
17. R. Zeig-Owens, S.T. Gershman, R. Knowlton, and J.S. Jacobson Survival and time interval from surgery to start of chemotherapy among colon cancer patients J Registry Manage 36 2 2009 30 41 [quiz 61-2]
18. J.J. Biagi, M.J. Raphael, W.J. Mackillop, W. Kong, W.D. King, and C.M. Booth Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis JAMA 305 22 2011 2335 2342
19. D.A. Etzioni, A.B. El-Khoueiry, and R.W. Beart Jr. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review Cancer 113 12 2008 3279 3289
20. C.Y. Hu, G.L. Delclos, W. Chan, and X.L. Du Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer Med Oncol 28 4 2011 1062 1074
21. A.P.C. Fritz, A. Jack, and et al. International Classification of Diseases for Oncology (ICD-O) 2000 World Health Organisation Geneva
22. C.G.F. Wittekind, R. Hutter, M. Klimpfinger, and L. Sobin TNM atlas 2004 Springer-Verlag Berlin
23. A. Berglund, B. Cedermark, and B. Glimelius Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III? Ann Oncol 19 2 2008 400 402
24. A.R. Day, G. Middleton, R.V. Smith, I.C. Jourdan, and T.A. Rockall Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival Colorectal Dis 16 5 2014 368 372
25. S.E. Tevis, B.M. Kohlnhofer, S. Stringfield, E.F. Foley, B.A. Harms, C.P. Heise, and et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival Dis Colon Rectum 56 12 2013 1339 1348
26. W.Y. Cheung, B.A. Neville, and C.C. Earle Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for stage II and III rectal cancer Dis Colon Rectum 52 6 2009 1054 1063 [discussion 64]
27. S. Ahmed, I. Ahmad, T. Zhu, F.P. Arnold, G. Faiz Anan, A. Sami, and et al. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study Dis Colon Rectum 53 10 2010 1432 1438
28. D.W. Wasserman, M. Boulos, W.M. Hopman, C.M. Booth, R. Goodwin, and J.J. Biagi Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer J Oncol Pract 2014
29. S. Hendren, J.D. Birkmeyer, H. Yin, M. Banerjee, C. Sonnenday, and A.M. Morris Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer Dis Colon Rectum 53 12 2010 1587 1593
30. V. Poylin, T. Curran, E. Lee, and D. Nagle Laparoscopic colectomy decreases the time to administration of chemotherapy compared with open colectomy Ann Surg Oncol 21 11 2014 3587 3591
31. A.M. Lacy, J.C. Garcia-Valdecasas, S. Delgado, A. Castells, P. Taura, J.M. Pique, and et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial Lancet 359 9325 2002 2224 2229
32. R.A. Popescu, R. Schafer, R. Califano, R. Eckert, R. Coleman, J.Y. Douillard, and et al. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO) Ann Oncol 25 1 2014 9 15